Venture Partners II Lp Meridian serves as Executive at BIOSANTE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Venture Partners II Lp Meridian has executed 13 insider transactions totaling $40.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 16, 2023 involved selling 200,000 shares valued at $11.7M.
Venture Partners II Lp Meridian currently holds 1,819,259 shares of BIOSANTE PHARMACEUTICALS INC (BPAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Venture Partners II Lp Meridian has been a net seller of BPAX stock. They have purchased $0 and sold $40.7M worth of shares.
Venture Partners II Lp Meridian's most recent insider trade was on Aug 16, 2023, when they sold 200,000 shares at $58.50 per share.
Get notified when new Form 4 filings are submitted
| $71.77 |
| Discretionary |
| Aug 12, 2019 | ANIP | $1.5M | Sale | 21,016 | $71.45 | Discretionary |
| Aug 9, 2019 | ANIP | $1.4M | Sale | 19,860 | $71.70 | Discretionary |
| Mar 12, 2015 | ANIP | $18.9M | Sale | 300,000 | $63.00 | Discretionary |
| Mar 13, 2014 | ANIP | $1.7M | Sale | 52,404 | $31.69 | Discretionary |
| Mar 13, 2014 | ANIP | $224.9K | Sale | 6,752 | $33.31 | Discretionary |
| Mar 13, 2014 | ANIP | $1.0M | Sale | 33,514 | $31.05 | Discretionary |
| Mar 13, 2014 | ANIP | $394.8K | Sale | 12,138 | $32.53 | Discretionary |
| Mar 12, 2014 | ANIP | $1.2M | Sale | 35,319 | $33.66 | Discretionary |
| Mar 12, 2014 | ANIP | $1.1M | Sale | 32,802 | $33.61 | Discretionary |
| Mar 12, 2014 | ANIP | $86.4K | Sale | 2,517 | $34.33 | Discretionary |
| Jun 19, 2013 | BPAX | $0 | Award | 16,918,469 | $N/A | Discretionary |